Compare LFVN & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFVN | LNSR |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.2M | 142.0M |
| IPO Year | N/A | N/A |
| Metric | LFVN | LNSR |
|---|---|---|
| Price | $6.22 | $11.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $35.00 | $15.00 |
| AVG Volume (30 Days) | ★ 193.0K | 44.5K |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | ★ 143.91 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $228,877,000.00 | $59,141,000.00 |
| Revenue This Year | $1.54 | $19.55 |
| Revenue Next Year | $7.00 | $35.89 |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | 16.77 | ★ 21.02 |
| 52 Week Low | $5.69 | $7.25 |
| 52 Week High | $27.38 | $17.31 |
| Indicator | LFVN | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 47.37 |
| Support Level | $5.80 | $11.19 |
| Resistance Level | $6.41 | $11.81 |
| Average True Range (ATR) | 0.34 | 0.31 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 66.51 | 18.61 |
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.